Research: RPC opinion: impact of Health Bill - medical device licensing

We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. You have accepted additional cookies. You can change your cookie settings at any time. You have rejected additional cookies. You can change your cookie settings at any time. Regulatory Policy Committee's opinion of the quality of the evidence and analysis in the impact assessment from Department of Health and Social Care. RPC opinion: impact of Health Bill - medical device licensing HTML The Regulatory Policy Committee (RPC) gave a ‘green’ rating to the impact assessment for the proposed medical device licensing regime in the Health Bill on 27 July 2026. This means that we considered the assessment to be ‘fit for purpose’ based on our scrutiny of the evidence and analysis supporting the case for why regulation is necessary. Our rating is advisory and does not reflect the merits of the policy itself. Do not include personal or financial information like your National Insurance number or credit card details. To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript ) .